Banco Santander, S.A. Pfizer Inc Transaction History

Banco Santander, S.A.

$8.29 Billion
Q1 2024

A detailed history of Banco Santander, S.A. transactions in Pfizer Inc stock. As of the latest transaction made, Banco Santander, S.A. holds 1,273,651 shares of PFE stock, worth $35.6 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

1,273,651

Previous 1,255,557 1.44%

Holding current value

$35.6 Million

Previous $36.1 Million 2.22%

% of portfolio

0.43%

Previous 0.43%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $468,453 - $537,934	18,094 Added 1.44%	1,273,651 $35.3 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $8.69 Million - $11.3 Million	332,695 Added 36.05%	1,255,557 $36.1 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $4.38 Million - $5.12 Million	136,510 Added 17.36%	922,862 $30.6 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $3.74 Million - $4.33 Million	103,671 Added 15.19%	786,352 $28.8 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $8.79 Million - $11.4 Million	223,110 Added 48.55%	682,681 $27.9 Million

Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $459,918 - $600,372	11,016 Added 2.46%	459,571 $23.6 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $397,559 - $485,320	-9,085 Reduced 1.99%	448,555 $19.6 Million
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $6 Million - $7.12 Million	128,971 Added 39.24%	457,640 $24 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $1.14 Million - $1.41 Million	24,907 Added 8.2%	328,669 $17 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $2.45 Million - $3.63 Million	59,239 Added 24.23%	303,762 $17.9 Million
Q3 2021 Nov 08, 2021	SELL	$39.25 - $50.42 $7.58 Million - $9.74 Million	-193,160 Reduced 44.13%	244,523 $10.5 Million
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $903,603 - $1.02 Million	25,163 Added 6.1%	437,683 $17.1 Million
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $822,648 - $927,782	24,564 Added 6.33%	412,520 $14.9 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $4.58 Million - $5.82 Million	-136,770 Reduced 26.07%	387,956 $14.3 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $232,759 - $273,079	-7,331 Reduced 1.38%	524,726 $19.3 Million
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $6.67 Million - $8.09 Million	221,463 Added 71.3%	532,057 $17.4 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $311,466 - $445,018	-11,523 Reduced 3.58%	310,594 $10.1 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $2.45 Million - $2.79 Million	74,561 Added 30.12%	322,117 $12.6 Million
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $413,435 - $536,104	-12,725 Reduced 4.89%	247,556 $8.89 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $757,905 - $850,952	-20,495 Reduced 7.3%	260,281 $11.3 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $750,337 - $824,370	-20,009 Reduced 6.65%	280,776 $11.9 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $5.37 Million - $6.12 Million	-139,594 Reduced 31.7%	300,785 $13.1 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $4.38 Million - $5.31 Million	127,092 Added 40.57%	440,379 $19.4 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $2.18 Million - $2.32 Million	-66,035 Reduced 17.41%	313,287 $11.4 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $43 Million - $49.8 Million	-1,346,539 Reduced 78.02%	379,322 $13.5 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $53.7 Million - $57 Million	1,614,946 Added 1456.02%	1,725,861 $62.5 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $1.75 Million - $1.92 Million	-56,360 Reduced 33.69%	110,915 $3.95 Million
Q2 2017 Aug 11, 2017	BUY	N/A	167,275	167,275 $5.62 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.

Account

Banco Santander, S.A. Pfizer Inc Transaction History